Tian Yan-Ge, Li Ya, Li Jian-Sheng, Li Su-Yun, Jiang Su-Li, Wang Ying, Deng Li, Wang Yuan-Yuan
Institute of Gerontology, Henan University of Traditional Chinese Medicine, Zhengzhou 450008, China.
Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(1):75-80.
To evaluate the impact and long-term effect of three prescriptions regulating and tonifying lung and kidney (prescription tonifying lung and spleen, prescription tonifying lung and kidney, and prescription tonifying Qi and kidney) on JAK/STAT signaling of COPD rats.
Rats were randomly divided into the control group, the model group, the Bufeijianpi group, the Bufeiyishen group, the Yiqizishen group and the aminophyline group. The COPD rat model was established by smoke inhalations and bacterial infections. In the 9th week, the control group and the model group were administered with normal saline, while the remaining groups are orally given corresponding medicines. In the 20th and 32nd week, the rats were sacrificed in batches to observe the pathology in their lung tissues, protein expressions of JAK2, STAT1, STAT3, STAT5, and expressions of JAK2 and SOCS3 mRNA.
In the 20th and 32nd week, protein expressions of JAK2 mRNA and phosphorylation-JAK2, STAT1, STAT3 and STAT5 in the model group were higher than the control group (P < 0.01), whereas the three traditional Chinese medicine (TCM) (Bufeijianpi, Bufeiyishen and Yiqizishen) groups and the aminophyline group were significantly lower (P < 0.05, P < 0.01). The expression of SOCS3 mRNA in the model group was higher than the control group (P < 0.01), whereas the level was notably higher in the three TCM groups and the aminophylline group (P < 0.01). The three TCM groups were remarkably higher than the aminophylline group (P < 0.05, P < 0.01). Compared with the figures in the 20th week, JAK2 mRNA and phosphorylation-JAK2, STAT3 and STAT5 were significantly lower in the Bufeijianpi group in the 32nd week (P < 0.05, P < 0.01), and so did phosphorylation-STAT3 in Bufeiyishen group (P < 0.01) and phosphorylation-STAT3 and STAT5 in the Yiqizishen group (P < 0.05, P < 0.01). However, the aminophylline group showed no significant difference in above indicators.
The three medicines regulating and tonifying lung and kidney can effectively relieve injury of lung tissues, and have long-term effect, which may be related to the regulation of JAK/ STAT signaling. Specifically, prescription tonifying lung and spleen shows good effect in reducing JAK2, STAT3 and STAT5, prescription tonifying lung and kidney shows good effect in reducing p-STAT3, and prescription tonifying Qi and kidney shows good effect in reducing p-STAT3 and p-STAT5.
评价三种肺肾双补方剂(补脾益肺方、补肺益肾方、益气滋肾方)对慢性阻塞性肺疾病(COPD)大鼠JAK/STAT信号通路的影响及长期疗效。
将大鼠随机分为对照组、模型组、补脾健脾组、补肺益肾组、益气滋肾组和氨茶碱组。采用烟熏和细菌感染法建立COPD大鼠模型。第9周时,对照组和模型组给予生理盐水,其余各组给予相应药物口服。在第20周和第32周,分批处死大鼠,观察肺组织病理学变化、JAK2、STAT1、STAT3、STAT5蛋白表达以及JAK2和SOCS3 mRNA表达。
在第20周和第32周,模型组JAK2 mRNA、磷酸化-JAK2、STAT1、STAT3和STAT5蛋白表达均高于对照组(P<0.01),而三种中药(补脾健脾、补肺益肾、益气滋肾)组和氨茶碱组均显著降低(P<0.05,P<0.01)。模型组SOCS3 mRNA表达高于对照组(P<0.01),而三种中药组和氨茶碱组水平显著更高(P<0.01)。三种中药组显著高于氨茶碱组(P<0.05,P<0.01)。与第20周相比,第32周补脾健脾组JAK2 mRNA、磷酸化-JAK2、STAT3和STAT5显著降低(P<0.05,P<0.01),补肺益肾组磷酸化-STAT3降低(P<0.01),益气滋肾组磷酸化-STAT3和STAT5降低(P<0.05,P<0.01)。然而,氨茶碱组上述指标无显著差异。
三种肺肾双补药物可有效减轻肺组织损伤,且具有长期疗效,这可能与调节JAK/STAT信号通路有关。具体而言,补脾益肺方在降低JAK2、STAT3和STAT5方面效果良好,补肺益肾方在降低p-STAT3方面效果良好,益气滋肾方在降低p-STAT3和p-STAT5方面效果良好。